Efgartigimod for the Treatment of Guillain-Barré Syndrome
NCT06885762
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
NOT_YET_RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Guillain-Barre Syndrome (GBS)
Interventions
DRUG:
efgartigimod
Sponsor
Zhongming Qiu